person

Dariusz K.

Country
Poland
Department
I Oddział Ginekologii Onkologicznej z Pododdziałem Brachyterapii

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
152
Sites with multiple studies

Has run more than one trial at 152 of 337 partner sites.

Specializations

Gynecologic Oncology

The investigator specializes in treating advanced and recurrent endometrial cancer, with particular focus on developing targeted therapeutic approaches. Their research encompasses evaluation of novel treatment modalities for patients with various stages of endometrial malignancies.

  • Advanced Endometrial Cancer Management
  • Recurrent Disease Treatment
  • Targeted Therapy Development

Their work extends to investigating maintenance therapy strategies for endometrial cancer patients.

Precision Medicine

The investigator focuses on biomarker-driven treatment approaches, particularly in studying therapies for patients with specific genetic profiles including TP53WT status and dMMR (deficient MisMatch Repair) characteristics.

  • Biomarker Analysis
  • Personalized Treatment Strategies
  • Genetic Profiling Applications

Their research contributes to advancing personalized therapeutic approaches in gynecologic oncology.

Therapeutic Innovation

The investigator explores multiple treatment modalities including immunotherapy and novel targeted agents. Their research encompasses both maintenance therapy strategies and comparative studies of different therapeutic approaches.

  • Novel Drug Development
  • Immunotherapy Applications
  • Treatment Optimization Studies

Their work includes evaluation of survival outcomes and treatment response in gynecologic cancers.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.